Skip to content
IDIBELL
  • Donate!
  • Contact
  • Intranet
  • En
    • Ca
    • Es
Below Header
  • The Institute
  • Research
  • Services
  • Innovation
  • News & Events
  • Scientific culture
  • Home
  • Translational Medicine Area
  • Genes, Disease and Therapy Program
  • Page 2

Genes, Disease and Therapy Program

03/10/2022

Researchers validate a microRNA as a biomarker for the diagnosis of azoospermia

10/06/2022

Large-scale genotyping identifies the molecular cause of two cases of familial globozoospermia

12/05/2022

A new system expands the gene-editing possibilities in animals

10/05/2022

IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus

16/02/2022

A worm model allows the study of adverse effects of the most common chemotherapy against solid tumors and improves its effectiveness

30/12/2021

We close a 2021 full of science!

29/12/2021

Finding new paths in the treatment of cystic fibrosis

19/11/2021

The first gene therapy approach for MLC leukoencephalopathy, designated as an orphan drug

18/11/2021

IDIBELL offers 10 projects for incoming INPhINIT fellowships

30/09/2021

Identified a possible biomarker for the appearance of stones in cystinuria

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next »

Direct links

  • Comittees and boards
  • Transparency
  • Complaints channel
  • Channel against discrimination and harassment
  • Legal notice
  • Privacy Policy
  • Privacy policy social networks

Follow us

  • 𝕏
  • Facebook
  • Youtube
  • Linkedin
  • Instagram

Contact

+34 93 607 38 00
info@idibell.cat

Localization

Hospital Duran i Reynals
2a planta Edifici Terapèutic
Av. Granvia de l’Hospitalet, 199
08908 L’Hospitalet de Llobregat (Barcelona)

IDIBELL
Copyright © 2025 Institut d’Investigació Biomèdica de Bellvitge
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Funcional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Scroll to Top